{"id":"https://openalex.org/W2561221972","doi":"https://doi.org/10.1111/bph.13697","title":"Anti\u2010CD22 and anti\u2010CD79b antibody\u2010drug conjugates preferentially target proliferating B cells","display_name":"Anti\u2010CD22 and anti\u2010CD79b antibody\u2010drug conjugates preferentially target proliferating B cells","publication_year":2016,"publication_date":"2016-12-25","ids":{"openalex":"https://openalex.org/W2561221972","doi":"https://doi.org/10.1111/bph.13697","mag":"2561221972","pmid":"https://pubmed.ncbi.nlm.nih.gov/28009435","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5368047"},"language":"en","primary_location":{"id":"doi:10.1111/bph.13697","doi":"https://doi.org/10.1111/bph.13697","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.13697","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.13697","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.13697","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018881780","display_name":"Franklin K. Fuh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Franklin K Fuh","raw_affiliation_strings":["Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015657862","display_name":"Caroline Looney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline Looney","raw_affiliation_strings":["Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100384469","display_name":"Dongwei Li","orcid":"https://orcid.org/0009-0003-0945-7357","observed_orcids":["https://orcid.org/0009-0003-0945-7357","https://orcid.org/0000-0001-8914-3021"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dongwei Li","raw_affiliation_strings":["Department of Pharmacokinetic and Pharmacodynamic Sciences, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetic and Pharmacodynamic Sciences, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018469778","display_name":"Kirsten Achilles Poon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]},{"id":"https://openalex.org/I4210097160","display_name":"Denali Therapeutics (United States)","ror":"https://ror.org/00pprn321","country_code":"US","type":"company","lineage":["https://openalex.org/I4210097160"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kirsten A Poon","raw_affiliation_strings":["Denali Therapeutics, Inc., South San Francisco, CA, USA","Department of Safety and Toxicology, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Denali Therapeutics, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210097160"]},{"raw_affiliation_string":"Department of Safety and Toxicology, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086858204","display_name":"Randall C. Dere","orcid":"https://orcid.org/0000-0003-4120-7828","observed_orcids":["https://orcid.org/0000-0003-4120-7828"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randall C Dere","raw_affiliation_strings":["Department of BioAnalytical Research and Development, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of BioAnalytical Research and Development, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048506216","display_name":"Dimitry M. Danilenko","orcid":"https://orcid.org/0000-0002-8326-1921","observed_orcids":["https://orcid.org/0000-0002-8326-1921"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dimitry M Danilenko","raw_affiliation_strings":["Department of Safety Assessment, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Safety Assessment, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023401644","display_name":"Jacqueline McBride","orcid":"https://orcid.org/0000-0002-0247-6569","observed_orcids":["https://orcid.org/0000-0002-0247-6569"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline McBride","raw_affiliation_strings":["Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014773643","display_name":"Chae Reed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chae Reed","raw_affiliation_strings":["Department of BioAnalytical Research and Development, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of BioAnalytical Research and Development, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047150251","display_name":"Shan Chung","orcid":"https://orcid.org/0000-0002-5494-2103","observed_orcids":["https://orcid.org/0000-0002-5494-2103"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shan Chung","raw_affiliation_strings":["Department of BioAnalytical Research and Development, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of BioAnalytical Research and Development, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025817932","display_name":"Bing Zheng","orcid":"https://orcid.org/0000-0003-3443-7297","observed_orcids":["https://orcid.org/0000-0003-3443-7297"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bing Zheng","raw_affiliation_strings":["Department of Immunology Research, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology Research, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005555736","display_name":"William Rodney Mathews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Rodney Mathews","raw_affiliation_strings":["Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022150086","display_name":"Andrew G. Polson","orcid":"https://orcid.org/0000-0003-3289-6502","observed_orcids":["https://orcid.org/0000-0003-3289-6502"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Polson","raw_affiliation_strings":["Department of Immunology Research, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology Research, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021714286","display_name":"Saileta Prabhu","orcid":"https://orcid.org/0000-0001-5436-9135","observed_orcids":["https://orcid.org/0000-0001-5436-9135"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Saileta Prabhu","raw_affiliation_strings":["Department of Pharmacokinetic and Pharmacodynamic Sciences, Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetic and Pharmacodynamic Sciences, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109234314","display_name":"Marna B. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marna Williams","raw_affiliation_strings":["Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA","MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamic Biomarkers, Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021714286"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":{"value":4780,"currency":"USD","value_usd":4780},"fwci":1.6094,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.82617791,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"174","issue":"8","first_page":"628","last_page":"640"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7813000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7813000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.14499999582767487,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.025499999523162842,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anti-cd22-antibody","display_name":"anti-CD22 antibody","score":0.8180000185966492},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.9670000076293945},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9039999842643738},{"id":"https://openalex.org/keywords/germinal-center-b-cells","display_name":"germinal center B cells","score":0.9789999723434448},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.7400000095367432},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8090000152587891},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9819999933242798},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.7680000066757202},{"id":"https://openalex.org/keywords/antimitotic-agents","display_name":"antimitotic agents","score":0.8840000033378601}],"concepts":[{"id":"https://openalex.org/C111700020","wikidata":"https://www.wikidata.org/wiki/Q5009798","display_name":"CD22","level":4,"score":0.7910398244857788},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.7471360564231873},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.715919017791748},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5438568592071533},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5432729125022888},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4808422029018402},{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.4804822504520416},{"id":"https://openalex.org/C96926380","wikidata":"https://www.wikidata.org/wiki/Q1737968","display_name":"Germinal center","level":4,"score":0.47353336215019226},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.444816529750824},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4348228871822357},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4040030837059021},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40312665700912476},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3618204891681671},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32542866468429565},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14369246363639832}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000937","descriptor_name":"Antigen-Antibody Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051918","descriptor_name":"Sialic Acid Binding Ig-like Lectin 2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051925","descriptor_name":"CD79 Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/bph.13697","doi":"https://doi.org/10.1111/bph.13697","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.13697","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.13697","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5368047","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5368047","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:28009435","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28009435","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/bph.13697","doi":"https://doi.org/10.1111/bph.13697","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.13697","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.13697","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2561221972.pdf","grobid_xml":"https://content.openalex.org/works/W2561221972.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W152943885","https://openalex.org/W206701898","https://openalex.org/W1593555249","https://openalex.org/W1888470382","https://openalex.org/W1911907131","https://openalex.org/W1946521533","https://openalex.org/W1967105697","https://openalex.org/W1968779484","https://openalex.org/W1980177098","https://openalex.org/W1985380203","https://openalex.org/W2001306967","https://openalex.org/W2008751117","https://openalex.org/W2033111644","https://openalex.org/W2035686327","https://openalex.org/W2069832110","https://openalex.org/W2089197481","https://openalex.org/W2090057677","https://openalex.org/W2101893838","https://openalex.org/W2115292116","https://openalex.org/W2123460144","https://openalex.org/W2124514746","https://openalex.org/W2124633824","https://openalex.org/W2126422041","https://openalex.org/W2127018518","https://openalex.org/W2127810505","https://openalex.org/W2158346246","https://openalex.org/W2173513233","https://openalex.org/W2191824243","https://openalex.org/W2193975711","https://openalex.org/W2194756172","https://openalex.org/W2321413400","https://openalex.org/W2508961955"],"related_works":["https://openalex.org/W2979422180","https://openalex.org/W2158346246","https://openalex.org/W2127810505","https://openalex.org/W7095611549","https://openalex.org/W116285198","https://openalex.org/W2554618617","https://openalex.org/W2033111644","https://openalex.org/W1780016453","https://openalex.org/W2152279497","https://openalex.org/W7096377637"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,186],"PURPOSE:":[2],"CD22":[3,167],"and":[4,28,42,44,76,80,90,139,158,168],"CD79b":[5,170],"are":[6],"cell-surface":[7],"receptors":[8],"expressed":[9],"on":[10,74],"B-cell-derived":[11],"malignancies":[12],"such":[13],"as":[14],"non-Hodgkin's":[15],"lymphoma":[16],"(NHL).":[17],"An":[18,119],"anti-mitotic":[19,219,223],"agent,":[20],"monomethyl":[21],"auristatin":[22,214],"E,":[23],"was":[24,107,124],"conjugated":[25],"to":[26,31,217,225,237],"anti-CD22":[27,63],"anti-CD79b":[29,65],"antibodies":[30,69,161,171,233],"develop":[32],"target-specific":[33],"therapies":[34],"for":[35],"NHL.":[36],"The":[37,188],"mechanism":[38],"of":[39,48,94,104,111,122,133,156,196,208,231],"action":[40],"(MOA)":[41],"pharmacological":[43],"pharmacokinetic":[45],"(PK)":[46],"profiles":[47,155,247],"these":[49],"antibody-drug":[50],"conjugates":[51],"(ADCs)":[52],"were":[53,61,83,97,146,162],"investigated":[54],"in":[55,99,126,137,144,149,242],"cynomolgus":[56],"monkeys.":[57],"EXPERIMENTAL":[58],"APPROACH:":[59],"Animals":[60],"administered":[62,128,151],"or":[64,70,114,174],"ADCs,":[66],"respective":[67,116,159],"unconjugated":[68,117,160],"vehicle.":[71],"Pharmacodynamic":[72],"effects":[73],"total":[75,197],"proliferating":[77,134,209],"B":[78,105,135,142,198,210,226,240],"cells":[79,106,136,143,199,211,227,241],"serum":[81],"PK":[82,154],"then":[84],"assessed.":[85],"Antibody-dependent":[86],"cellular":[87],"cytotoxicity":[88,92],"(ADCC)":[89],"complement-dependent":[91],"(CDC)":[93],"the":[95,115,191,213,229],"ADCs":[96,157],"evaluated":[98],"vitro.":[100],"KEY":[101],"RESULTS:":[102],"Depletion":[103],"observed":[108,125,148],"after":[109],"administration":[110],"either":[112],"ADC":[113],"antibodies.":[118],"extended":[120],"duration":[121],"depletion":[123,132,195,207],"animals":[127,150],"ADCs.":[129,152],"Similarly,":[130],"preferential":[131],"blood":[138],"germinal":[140],"centre":[141],"spleen":[145],"only":[147,175],"Serum":[153],"comparable.":[163],"In":[164],"vitro,":[165],"anti-human":[166,169],"showed":[172],"no":[173],"moderate":[176],"ADCC":[177],"activity,":[178],"respectively;":[179],"neither":[180],"antibody":[181],"had":[182],"CDC":[183],"activity.":[184],"CONCLUSIONS":[185],"IMPLICATIONS:":[187],"findings":[189],"support":[190],"proposed":[192],"MOA:":[193],"initial":[194],"by":[200,204,212],"antibody-mediated":[201],"opsonization,":[202],"followed":[203],"preferential,":[205],"sustained":[206],"conjugate":[215],"due":[216],"its":[218],"action.":[220],"Delivering":[221],"potent":[222],"agents":[224],"via":[228],"specificity":[230],"monoclonal":[232],"provides":[234],"a":[235],"means":[236],"eliminate":[238],"pathogenic":[239],"NHL":[243],"with":[244],"improved":[245],"risk-benefit":[246],"over":[248],"traditional":[249],"chemotherapeutics.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}